Selectivity and potency of new basic CCK-B antagonists.
Rovati
L C
LC
Rotta Research Laboratorium S.p.A., Monza (MI), Italy.
D'Amato
M
M
Peris
W
W
Revel
L
L
Makovec
F
F
D000818:Animals; D001549:Benzamides / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology; D004285:Dogs; D005402:Fistula; D005744:Gastric Acid / Q000378:metabolism*; D005753:Gastric Mucosa / Q000187:drug effects / Q000378:metabolism*; D005755:Gastrins / Q000037:antagonists & inhibitors; D006632:Histamine / Q000494:pharmacology; D007651:Keto Acids / Q000494:pharmacology*; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology; D010418:Pentagastrin / Q000494:pharmacology; D010421:Pentanoic Acids / Q000494:pharmacology; D051381:Rats; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors* / Q000378:metabolism; D013141:Spiro Compounds / Q000494:pharmacology*; D013237:Stereoisomerism; D013270:Stomach / Q000601:surgery
D001549:Benzamides; D005755:Gastrins; D007651:Keto Acids; D010421:Pentanoic Acids; D011949:Receptors, Cholecystokinin; D013141:Spiro Compounds; D006632:Histamine; D002217:Carbachol; D010418:Pentagastrin; C076954:spiroglumide